Confined to Hong Kong, Lung Fung lacks tonic for growth-hungry investors
The city’s leading pharmacy chain reported record revenue and profits in its latest fiscal year, lifting its shares Key Takeaways: Lung Fung reported its profit reached HK$269 million in its…
Recent Articles
RELATED ARTICLES
-
China’s shrinking ‘Chicken King’ scurries towards Hong Kong IPO
- Qdama’s ‘No Yesterday’s Meat’ model stumbles on path to Hong Kong listing
- Local chick LXJ eyes big city lights with third Hong Kong IPO bid
- ‘Plum king’ sweetens fourth IPO bid with new products, price cuts
- JD.com pours $4.5 billion into Hong Kong. But when will it recoup that money?
-
Struggling Shimao looks on as creditors move in on its trophy Hong Kong hotel
0813.HK
- JD Health’s AI push sets up a battle of the digital doctors
